Federal prosecutors open criminal probe into MLBPA's Players Way venture amid allegations of self-dealing and misuse of union resources.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Federal prosecutors open criminal probe into MLBPA's Players Way venture amid allegations of self-dealing and misuse of union resources.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.